$5.85
-0.100 (-1.68%)
At Close: Jun 03, 2026
Enzon Pharmaceuticals (ENZN) and Its Rivals Financial Contrast
06:18pm, Tuesday, 16'th Nov 2021 Transcript Daily
Enzon Pharmaceuticals (OTCMKTS: ENZN) is one of 232 publicly-traded companies in the Biological products, except diagnostic industry, but how does it compare to its peers? We will compare Enzon Pharmaceuticals to related companies based on the strength of its profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Valuation and Earnings This table compares []
CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Com
Sign In
Buy ENZN